Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2026-02-27 @ 10:33 AM
Study NCT ID:
NCT05405166
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-14
First Post:
2022-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Sponsor:
Sanofi
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Plasma Cell Myeloma Recurrent | View |
Keywords: